Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer

and pharmaceutically acceptable salts thereof, where R1, R2, R3 and R4 have any of the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pha...

Full description

Saved in:
Bibliographic Details
Main Authors HUNT, Thomas Anthony, PIKE, Kurt Gordon, BARLAAM, Bernard Christophe, EATHERTON, Andrew John
Format Patent
LanguageEnglish
Published 04.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:and pharmaceutically acceptable salts thereof, where R1, R2, R3 and R4 have any of the meanings defined herein. The specification also relates to the use of compounds of Formula (I) and salts thereof to treat or prevent ATM mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising substituted imidazo[4,5-c]quinolin-2-one compounds and pharmaceutically acceptable salts thereof; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; and intermediates useful in such manufacture.
Bibliography:Application Number: US201615772120